Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results.

@article{Toth2017WhyPS,
  title={Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results.},
  author={Peter P. Toth and Warren Stevens and Jacquelyn W Chou},
  journal={Journal of medical economics},
  year={2017},
  volume={20 7},
  pages={749-751}
}
Why have published studies of the cost effectiveness of PCSK-9 inhibitors yielded such markedly different results Peter P. Toth, Warren Stevens & Jacquelyn W. Chou To cite this article: Peter P. Toth, Warren Stevens & Jacquelyn W. Chou (2017): Why have published studies of the cost effectiveness of PCSK-9 inhibitors yielded such markedly different results, Journal of Medical Economics, DOI: 10.1080/13696998.2017.1327440 To link to this article: http://dx.doi.org/10.1080/13696998.2017.1327440 
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
1 Citations
15 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Methods for the economic evaluation of health care programmes: Oxford university

  • MF Drummond, MJ Sculpher, K Claxton, GL Stoddart, GW. Torrance
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…